Propella Therapeutics

Pittsboro, United States Founded: 2020 • Age: 6 yrs Acquired By Astellas Pharma
Therapeutics for cancer and arthritis are developed through API repositioning.

About Propella Therapeutics

Propella Therapeutics is a company based in Pittsboro (United States) founded in 2020 was acquired by Astellas Pharma in December 2023.. Propella Therapeutics operates in a competitive market with competitors including Flexion Therapeutics, Formation Bio, Eupraxia Pharmaceuticals, MRM Health and Radionetics, among others.

  • Headquarter Pittsboro, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Astellas Pharma

    (Dec 22, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Propella Therapeutics
Headcount 1-10
Employee Profiles 1
Board Members and Advisors 6
Employee Profiles
People
William Moore
Director, President & CEO

Unlock access to complete

Teams

Funding Insights of Propella Therapeutics

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Propella Therapeutics

Propella Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Astellas Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Generic pharmaceuticals are developed, manufactured, and marketed worldwide.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Propella Therapeutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Propella Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Propella Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Propella Therapeutics

Propella Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Formation Bio, Eupraxia Pharmaceuticals, MRM Health and Radionetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of therapies for the treatment of musculoskeletal disorders
domain founded_year HQ Location
AI-powered drug discovery platform for various diseases
domain founded_year HQ Location
Sustained-release drug delivery platform for osteoarthritis therapies is developed.
domain founded_year HQ Location
Developer of optimized consortia therapeutics targeting inflammatory, CNS, and metabolic diseases
domain founded_year HQ Location
Peptide-targeted radiopharmaceuticals for cancer treatment are developed.
domain founded_year HQ Location
Develops small molecule based drug for multiple disease treatment
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Propella Therapeutics

Frequently Asked Questions about Propella Therapeutics

When was Propella Therapeutics founded?

Propella Therapeutics was founded in 2020.

Where is Propella Therapeutics located?

Propella Therapeutics is headquartered in Pittsboro, United States. It is registered at Pittsboro, North Carolina, United States.

Who is the current CEO of Propella Therapeutics?

William Moore is the current CEO of Propella Therapeutics.

What does Propella Therapeutics do?

Propella Therapeutics was founded in 2020 and is located in Pittsboro, United States. Focus is placed on the biotech sector, where active pharmaceutical ingredients are redesigned and repositioned to create therapies for cancer and arthritis. PRL-02 is being developed as a testosterone-suppression agent for prostate cancer. The lead candidate, topical CGS-200-5 containing 5 capsaicin, is evaluated in phase-2 clinical trials for osteoarthritis knee pain reduction.

Who are the top competitors of Propella Therapeutics?

Propella Therapeutics's top competitors include Flexion Therapeutics, Formation Bio and Eupraxia Pharmaceuticals.

Who are Propella Therapeutics's investors?

Propella Therapeutics has 1 investor. Key investors include Astellas Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available